Advances in Alzheimer’s disease’s pharmacological treatment

Advances in Alzheimer’s disease’s pharmacological treatment

Alzheimer’s disease (AD) is the most common type of dementia in the elderly. Several hypotheses emerged from AD pathophysiological mechanisms. However, no neuronal protective or regenerative drug is available nowadays. Researchers still work in drug development and are finding new molecular targets...

Full description

Bibliographic Details
Main Authors: Carlos Elias Conti Filho, Lairane Bridi Loss, Clairton Marcolongo-Pereira, Joamyr Victor Rossoni Junior, Rafael Mazioli Barcelos, Orlando Chiarelli-Neto, Bruno Spalenza da Silva, Roberta Passamani Ambrosio, Fernanda Cristina de Abreu Quintela Castro, Sarah Fernandes Teixeira, Nathana Jamille Mezzomo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Pharmacology
Subjects:
Alzheimer’s disease
molecular target
drug development
pharmacological treatment
new drugs
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1101452/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1101452/full

Similar Items